# Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer

> **NCT02610426** · — · RECRUITING · sponsor: **National Cancer Institute (NCI)** · enrollment: 162 (estimated)

## Conditions studied

- Breast Carcinoma

## Interventions

- **OTHER:** Laboratory Biomarker Analysis

## Key facts

- **NCT ID:** NCT02610426
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2014-03-25
- **Primary completion:** 2100-01-01
- **Final completion:** 2100-01-01
- **Target enrollment:** 162 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02610426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02610426, "Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02610426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*